Stochter | Your Place for Smart Finance News, Investing Tips & Community

NYSE:PLTR

Palantir Stock Soars 23% After Blowout Q2 Results and Massive Guidance Increase

Palantir Technologies (NASDAQ: PLTR) surged 23% on Tuesday after delivering another blockbuster quarterly report that significantly exceeded Wall Street expectations. The AI software company reported explosive revenue growth, record commercial demand and sharply raised its full-year outlook, reinforcing its position as one of the biggest beneficiaries of accelerating enterprise AI adoption.

Second-quarter revenue jumped 93% year over year to $1.94 billion, while U.S. commercial revenue surged an extraordinary 149% to $764 million. Total U.S. revenue climbed 115% to $1.57 billion, supported by continued strength across both commercial and government customers.

U.S. Commercial Business Continues to Accelerate

The company's commercial momentum remained the key highlight of the quarter. Palantir closed a record $2.13 billion in U.S. commercial total contract value (TCV), up 153% from a year ago, while U.S. commercial remaining deal value increased 124% to $6.24 billion.

Overall, the company closed 220 deals worth at least $1 million during the quarter, including 73 contracts exceeding $10 million. Total contract value reached $3.37 billion, up 49% year over year, highlighting sustained demand for Palantir's AI-driven software platform.

CEO Alex Karp said growing demand for "AI sovereignty" is driving organizations toward platforms that allow customers to retain full control of their data while deploying artificial intelligence at scale.

Profitability and Cash Flow Reach New Highs

Palantir also demonstrated exceptional profitability alongside its rapid growth. GAAP operating income reached $912 million, representing a 47% operating margin, while adjusted operating income climbed to $1.19 billion, or 62% of revenue.

GAAP net income totaled $1.06 billion, with both adjusted free cash flow and cash from operations exceeding $1.2 billion. The company ended the quarter with $9.2 billion in cash, cash equivalents and short-term U.S. Treasury securities, providing significant financial flexibility.

Guidance Raised Well Above Expectations

Management substantially increased its 2026 outlook, now expecting full-year revenue between $8.15 billion and $8.16 billion, representing approximately 82% annual growth. The company also raised its U.S. commercial revenue forecast to more than $3.42 billion, implying at least 134% growth, while increasing adjusted operating income guidance to as much as $4.90 billion.

## What to Watch

Tuesday's rally reflects investor confidence that Palantir remains one of the strongest AI growth stories in the market. Investors will now focus on whether the company can sustain its exceptional commercial growth, continue converting large enterprise contracts into recurring revenue, and maintain its industry-leading profitability as AI adoption accelerates globally.

💬

European Investor 08-04-26

Palantir (PLTR) Stock Rises After DA Davidson Upgrades Shares to Buy

Palantir Technologies (NASDAQ: PLTR) shares gained approximately 3.5% on Thursday after DA Davidson upgraded the software company to Buy from Neutral and raised its price target to $175 from $165.

The upgrade comes as Palantir continues to benefit from strong investor enthusiasm surrounding artificial intelligence, with the company expanding its presence across both commercial and government markets through its AI-driven software platforms.

DA Davidson upgraded the stock and increased its price target, reflecting a more constructive outlook on the shares. The positive analyst action added to investor optimism surrounding Palantir's long-term growth potential.

Palantir has been one of the strongest performers in the software sector this year as enterprises continue increasing investments in AI applications, data analytics, and automation. The company has also continued to win government contracts while expanding adoption of its Artificial Intelligence Platform (AIP) among commercial customers.

# Why PLTR Stock Rose

Several factors supported the stock:

* DA Davidson upgraded Palantir to Buy from Neutral.
* The firm raised its price target to $175 from $165.
* Continued optimism around enterprise AI adoption and government demand has supported investor sentiment toward Palantir.
* The company remains well positioned to benefit from growing investment in AI-powered software and data analytics.

The combination of a rating upgrade and continued optimism surrounding the AI sector helped lift Palantir shares approximately 3.5% during Thursday's trading session.

💬

Global Finance News 07-02-26

Palantir Stock Gains After Analyst Upgrades Shares to Buy

Palantir Technologies (NASDAQ: PLTR) shares rose 4% on Monday after President Capital upgraded the stock to Buy from Neutral and significantly increased its price target, reinforcing bullish sentiment toward the AI software company.

The firm raised its price target to $133 from $25.50, reflecting increased confidence in Palantir's growth trajectory as demand for artificial intelligence, data analytics, and defense software platforms continues to expand.

The upgrade comes as Palantir continues to benefit from strong adoption of its AI-powered platforms across both government and commercial customers. Investors remain optimistic that accelerating enterprise AI deployment and growing federal contracts will support robust revenue growth in the coming quarters.

The analyst action also coincided with a broader rally in technology stocks, supported by easing geopolitical tensions between the United States and Iran and improving investor risk appetite.

At the time of writing, Palantir shares were trading around $117, up approximately 4% during Monday's session as investors welcomed the bullish analyst upgrade.

💬

European Investor 06-29-26

Palantir Slips as Wall Street Issues Mixed Ratings

Palantir Technologies (NASDAQ: PLTR) shares fell 2.7% as investors digested a wave of new analyst coverage that highlighted both the company's strong artificial intelligence prospects and concerns about its elevated valuation.

The stock received mixed treatment from Wall Street. UBS upgraded Palantir and assigned a Buy rating with a $200 price target, reflecting optimism about the company's growing role in the AI software market and expanding commercial business. Wedbush also initiated coverage with an Outperform rating, reinforcing the bullish case for continued growth.

However, not all analysts share that enthusiasm. BTIG Research downgraded the stock to Neutral, while Benchmark moved to Hold. BNP Paribas Exane initiated coverage with an Underperform rating, signaling concerns that recent years' gains may have outpaced fundamentals.

The conflicting analyst views come after Palantir's remarkable rally over the past 2 years, driven by surging demand for its Artificial Intelligence Platform (AIP), expanding government contracts, and accelerating adoption among commercial customers. The company has emerged as one of the market's most prominent AI beneficiaries, helping push its valuation to levels that have divided analysts.

The stock's decline suggests investors are taking a more cautious stance following its strong run, with valuation concerns temporarily outweighing enthusiasm for the company's growth prospects. Still, the presence of multiple bullish ratings and a $200 price target from UBS indicates that many analysts continue to see substantial long-term upside tied to Palantir's leadership in enterprise AI.

The mixed ratings underscore the central debate surrounding Palantir: whether its rapid growth in AI-driven software can justify one of the market's richest valuations.

💬

Global Finance News 06-16-26

Palantir Falls 4.5% in Market Selloff Despite Analysts Reaffirming Bullish Views

Palantir Technologies shares fell 4.5% on Friday as a broad technology selloff swept through U.S. markets, even as Wall Street analysts continued to express confidence in the company's long-term prospects.

The stock's decline came amid one of the sharpest drops in technology shares this year, with investors reacting to stronger-than-expected U.S. employment data that pushed Treasury yields higher and reduced expectations for near-term Federal Reserve rate cuts. High-growth technology companies were among the hardest hit as investors reassessed valuations in a higher-rate environment.

Despite the market weakness, analysts remained firmly positive on Palantir. Wedbush analyst Dan Ives reiterated his Outperform rating and maintained a $230 price target, while Rosenblatt Securities analyst John McPeake reaffirmed a Buy rating with a $225 target. Both targets imply substantial upside from the stock's closing price near $136.

The bullish stance reflects continued optimism surrounding Palantir's position in the rapidly expanding artificial intelligence market. The company has emerged as one of the most visible beneficiaries of enterprise AI adoption, with its Artificial Intelligence Platform (AIP) helping businesses and government agencies deploy AI applications using their own data. Strong demand from both commercial and government customers has fueled rapid revenue growth and improved profitability over the past year.

💬

The Investor 06-06-26

Palantir Drops 3% Pre-Market Despite Record Q1 Growth — Valuation Fears Persist

May 5, 2026

Palantir Technologies (NASDAQ: PLTR) slipped roughly 3% in Tuesday's pre-market session, even after delivering what the company called its strongest quarter ever. The pattern is now familiar: record numbers, raised guidance, and a stock that still falls.

Q1 by the Numbers

Total revenue came in at $1.633 billion, up 85% year-over-year — the company's highest-ever annual growth rate — easily clearing the $1.54 billion consensus estimate (Yahoo Finance). The U.S. business drove the outperformance: U.S. revenue hit $1.282 billion, up 104% year-over-year, with U.S. commercial revenue surging 133% to $595 million and U.S. government revenue rising 84% to $687 million.

Profitability was equally striking. GAAP net income reached $871 million (53% margin), adjusted free cash flow came in at $925 million, and the company's Rule of 40 score — which combines revenue growth and profit margin — hit 145%, a level CEO Alex Karp said has been matched only by NVIDIA, Micron, and SK Hynix among AI infrastructure peers (Palantir Earnings Release).

Guidance Raised Again

Management lifted full-year 2026 revenue guidance to $7.650–$7.662 billion, implying 71% growth — roughly 10 percentage points above what was guided just one quarter ago. U.S. commercial revenue guidance was raised to at least $3.224 billion, representing 120% growth. Adjusted free cash flow guidance was lifted to $4.2–$4.4 billion (Palantir Earnings Release).

The Valuation Problem

Despite the blowout results, the stock's extreme valuation continues to weigh on sentiment. Palantir entered 2026 with a trailing price-to-sales ratio above 100 (Motley Fool), and even after a roughly 20% pullback from its October 2025 all-time highs (Motley Fool), the stock trades at approximately 225 times trailing earnings and a forward price-to-sales ratio near 49 (Perplexity Finance). RBC Capital Markets maintained a bearish stance, flagging the valuation at around 50 times 2026 revenue estimates as unsustainable (Perplexity Finance). For comparison, Nvidia — growing at a similar pace — trades at roughly 44 times trailing earnings (Motley Fool).

This is not new territory. After Palantir's Q4 2025 earnings — themselves a beat-and-raise — shares fell more than 11% the following session on the same valuation concerns (24/7 Wall St.). The pre-market dip today, while painful, is relatively mild by recent standards.

Bull vs. Bear

Wedbush holds an Outperform rating with a $230 price target, calling Palantir a potential trillion-dollar AI company, while Oppenheimer initiated with an Outperform and $200 target ahead of earnings (Perplexity Finance). Bears counter that no level of revenue growth justifies a P/S ratio above 70, and that significant insider selling — $435 million worth of shares in the past three months — signals caution at the top (GuruFocus).

Palantir's Q1 was, by any measure, exceptional. Whether the stock can grow into its valuation is a question the market is still refusing to answer with a buy.

💬

The Investor 05-05-26

Palantir Technologies has signed a $300 million agreement with the U.S. Department of Agriculture to modernize digital services for farmers and strengthen agricultural security. The partnership supports the “One Farmer, One File” initiative, aimed at simplifying access to USDA programs through digital tools and reducing administrative burdens.

Palantir’s software will enhance data integration, improve service delivery, and help detect risks such as fraud and supply chain vulnerabilities. The system is also expected to accelerate payments and disaster recovery support for farmers, while consolidating legacy IT systems into a unified platform.

Source: Business Wire

💬

Global Finance News 04-24-26

Palantir’s Stock Is Down 15% YTD: Should You Brace for More Volatility?

Explore Palantir's significant stock drop of 15% year to date and whether more volatility is on the horizon for investors.

(thesmartinvestor.com.sg)

💬

European Investor 04-23-26

Palantir Technologies Inc. (NASDAQ: PLTR) announced today that results for its first quarter ended March 31, 2026 will be released on Monday, May 4, 2026, following the close of U.S. markets.

💬

WS Investor 04-14-26

Palantir Technologies Inc. announced the renewal and expansion of its partnership with Stellantis for an additional five years.

The agreement extends a collaboration that began in 2016 and will see Stellantis expand its use of Palantir’s Foundry platform while introducing the Artificial Intelligence Platform (AIP) across selected operations.

The combined technologies aim to integrate data and AI into core business processes, improving decision-making, transparency, and operational efficiency across Stellantis’ global industrial activities.

The partnership also supports Stellantis’ broader data strategy by enabling secure and scalable use of AI, reinforcing its transition toward a more data-driven and AI-powered enterprise.
Business Wire

💬

WS Investor 03-30-26

08-04-26European Investor

08-03-26WS News

07-08-26WS News

US

U.S. Job Openings Fall, Factory Orders Disappoint as Atlanta Fed Lowers GDPNow Forecast

U.S. economic data released on Tuesday painted a mixed picture of the economy, with labor demand and manufacturing activity showing signs of cooling while growth expectations were revised lower.

The JOLTS Job Openings report showed vacancies fell to 7.359 million in June, below both the 7.440 million consensus estimate and May’s revised 7.537 million. The decline suggests labor demand continues to moderate, supporting expectations that the U.S. job market is gradually cooling after remaining resilient for much of the year.

Manufacturing data also came in weaker than expected. Factory Orders declined 0.3% month-over-month in June, missing expectations for a 0.2% increase. However, the result represented an improvement from May’s revised 1.1% decline, indicating that manufacturing activity remains under pressure despite stabilizing from the previous month.

Meanwhile, the Atlanta Federal Reserve lowered its closely watched GDPNow estimate for third-quarter U.S. economic growth to 5.9% from 6.2%. Although the forecast remains exceptionally strong by historical standards, the downward revision reflects a slightly softer near-term economic outlook following the latest data releases.

The figures come after recent U.S. manufacturing PMI reports surprised to the upside, highlighting a mixed macroeconomic backdrop. While manufacturing activity has shown resilience, softer labor demand, weaker factory orders and a modest reduction in growth expectations suggest parts of the economy are beginning to lose momentum.

Investors will continue monitoring upcoming labor market and inflation data for further clues on the Federal Reserve’s policy path, as signs of slowing economic activity could strengthen expectations for future interest rate cuts if inflation continues to moderate.

💬

WS News 08-04-26

U.S. Stocks Climb as AI Earnings Momentum and Strong Economic Data Offset Geopolitical Uncertainty

U.S. stocks moved higher on Tuesday, with technology shares once again leading the market as investors welcomed another round of strong AI-relase earnings, upbeat economic data and easing concerns over the U.S.-Iran conflict.

The Nasdaq gained 1.38%, outperforming the broader market, while the Dow Jones Industrial Average rose 0.99% and the S&P 500 advanced 0.72%. The rally reflected continued confidence in artificial intelligence spending and corporate earnings despite ongoing geopolitical uncertainty.

AI Optimism Strengthens After Palantir's Strong Results

Technology stocks received another boost after Palantir reported exceptional quarterly results that reinforced optimism surrounding enterprise AI adoption. The company posted a 93% year-over-year increase in revenue, raised its full-year guidance and highlighted accelerating demand from both government and commercial customers. Shares surged following the report, extending the positive sentiment that has supported AI-related stocks throughout the earnings season.

The upbeat results added to investor confidence after last week's strong earnings from major technology companies, reinforcing expectations that AI investment remains one of the strongest themes driving corporate growth.

Manufacturing Data Signals Continued Economic Strength

Economic data also supported the market. The ISM Manufacturing PMI climbed to 55.6 in July from 53.3, well above expectations of 54.0 and marking the strongest expansion in the manufacturing sector in several years. The S&P Global Manufacturing PMI also remained solid at 53.9, while the ISM Prices Index eased to 71.1 from 73.0, suggesting inflationary pressures continued to moderate even as factory activity accelerated.

Lower Oil Prices Improve Market Sentiment

Investor confidence was further boosted by reports that diplomatic efforts between the United States and Iran continue to make progress, reducing fears of prolonged supply disruptions in the Middle East. The resulting decline in crude oil prices eased inflation concerns and supported sectors such as technology, consumer discretionary and industrials, although energy shares lagged the broader market.

What to Watch

Investors will now focus on upcoming labor market data and additional corporate earnings to assess whether the current rally can continue. AI-related earnings remain a key catalyst for technology stocks, while developments in U.S.-Iran negotiations and the direction of oil prices are likely to remain important drivers of broader market sentiment.

💬

European Investor 08-04-26

U.S. Trade Deficit Narrows in June

The U.S. trade deficit narrowed to $73.3 billion in June, improving from a revised $77.6 billion in May as the gap between exports and imports continued to shrink. Although the reading was slightly wider than economists' expectation of a $73.0 billion deficit, it marked a notable improvement from the previous month.

💬

European Investor 08-04-26

US Manufacturing Activity Accelerates in July as ISM Beats Expectations

U.S. manufacturing data painted a stronger-than-expected picture on Monday, with both the S&P Global Manufacturing PMI and the closely watched ISM Manufacturing PMI signaling improving factory activity. The stronger readings reinforced expectations that the industrial sector continues to recover despite elevated interest rates and ongoing trade uncertainty.

The ISM Manufacturing PMI rose to 55.6 in July, well above the market expectation of 54.0 and up from 53.3 in June. The reading points to an acceleration in manufacturing activity and suggests that new orders and production remained resilient at the start of the third quarter.

The earlier-released S&P Global Manufacturing PMI also came in at 53.9, slightly above the consensus forecast of 53.8 and matching June’s reading, indicating that manufacturing growth remained steady across a broad range of industries.

Inflation Pressures Ease Slightly but Remain Elevated

The ISM Manufacturing Prices Index declined to 71.1 from 73.0 in June, although it still exceeded expectations of 70.0. The lower reading suggests that input cost pressures continued to moderate but remained elevated, indicating inflation risks have eased somewhat without disappearing.

For investors, the combination of stronger manufacturing activity and gradually cooling price pressures is generally viewed as constructive, as it points to continued economic expansion without a significant resurgence in inflation.

What to Watch

Markets will now turn their attention to upcoming labor market and inflation data to assess whether the U.S. economy can maintain its current momentum. Investors will also monitor future Federal Reserve commentary to determine whether resilient economic activity and still-elevated price pressures could influence the outlook for interest rates in the coming months.

💬

WS News 08-03-26

US Stocks Slip as Stronger Economic Data Reinforces Fed Caution

U.S. stocks traded modestly lower on Friday, with the S&P 500 falling 0.23%, as investors digested a fresh batch of economic data pointing to resilient economic activity while weighing the implications for Federal Reserve policy.

The latest reports painted a mixed but generally constructive picture of the U.S. economy. Chicago PMI unexpectedly rose to 57.6 in July, beating expectations of 56.0 and improving from 56.7 in June, signaling that manufacturing activity in the Chicago region continued to expand at a healthy pace.

Consumer confidence also showed signs of improvement. The University of Michigan Consumer Sentiment Index increased to 55.2 from 49.5 in the previous month, surpassing the consensus estimate of 54.4. Meanwhile, the Consumer Expectations Index climbed to 55.4 from 50.7, also exceeding forecasts, suggesting households have become more optimistic about future economic conditions.

Inflation expectations offered additional encouragement. The University of Michigan's one-year inflation expectation remained unchanged at 4.2%, improving from the preliminary reading of 4.6% and matching market expectations. The stable inflation outlook may provide some reassurance that inflation pressures are not reaccelerating despite continued economic resilience.

Despite the largely positive data, markets remained under pressure as stronger economic activity could reinforce the Federal Reserve's cautious approach toward future interest rate cuts. Investors are increasingly balancing encouraging growth signals against the prospect that policymakers may keep borrowing costs elevated for longer if the economy continues to outperform expectations.

What to Watch

Markets will continue to monitor upcoming labor market and inflation data for further clues on the Fed's policy path. Investors will also remain focused on corporate earnings and management guidance as companies assess the impact of interest rates, consumer demand and ongoing macroeconomic uncertainty during the second half of the year.

💬

The Investor 07-31-26

Nasdaq Leads U.S. Markets Higher as Tech Earnings Fuel Rally

U.S. stocks traded broadly higher on Thursday, with the Nasdaq outperforming after another wave of stronger-than-expected corporate earnings reinforced optimism around artificial intelligence, cloud computing and technology spending.

At the time of writing, the Nasdaq was up 1.95%, while the S&P 500 gained 0.78% and the Dow Jones Industrial Average advanced 0.23%.

Technology stocks were the primary drivers of the rally, as investors continued to rotate into AI-related names following another round of upbeat quarterly results. Strong earnings from companies including Microsoft, Lam Research, Trane Technologies, Regeneron and Yum! Brands helped support broader market sentiment, while several companies also raised their full-year guidance, reinforcing confidence in corporate earnings despite ongoing macroeconomic uncertainty.

Industrial and infrastructure-related companies also attracted buying interest. Trane Technologies surged after reporting record bookings and raising its annual outlook, while Air Products advanced after exceeding adjusted earnings expectations and increasing its full-year EPS guidance despite large one-time restructuring charges.

Healthcare was another area of strength, with Regeneron posting double-digit revenue growth driven by Dupixent, EYLEA HD and Libtayo. Meanwhile, Enterprise Products Partners edged higher after reporting record earnings and cash flow supported by strong pipeline and terminal volumes.

Not all earnings reactions were positive. Investors sold shares of several defensive healthcare and consumer companies despite solid quarterly results. Bristol Myers Squibb, Sanofi and Altria all declined after reporting earnings, suggesting investors remain selective and continue to focus on long-term growth prospects rather than headline beats alone.

Attention now turns to the remainder of the earnings season and upcoming economic data, with investors watching whether the current momentum in AI, industrial spending and corporate profitability can continue supporting U.S. equities near record highs.

💬

WS Investor 07-30-26

US Jobless Claims Fall Unexpectedly, Signaling Continued Labor Market Strength

The number of Americans filing for unemployment benefits fell more than expected last week, highlighting the continued resilience of the U.S. labor market despite signs of slowing economic growth.

Initial jobless claims declined to 197,000, beating market expectations of 201,000 and improving from the previous week's revised reading of 188,000. The lower-than-expected figure suggests layoffs remain historically low and employers continue to retain workers.

Labor Market Remains Resilient

Continuing jobless claims, which measure the number of people receiving ongoing unemployment benefits, also came in stronger than expected. Claims fell to 1.782 million, below the consensus estimate of 1.800 million and down from 1.789 million previously.

The data indicate that unemployed workers are continuing to find new jobs relatively quickly, reinforcing the view that the labor market remains fundamentally healthy.

Mixed Picture for the Federal Reserve

The stronger labor market data follows weaker-than-expected second-quarter GDP growth and softer June PCE inflation figures released earlier in the day. Together, the reports present a mixed picture for the Federal Reserve, with easing inflation supporting the case for future policy easing while labor market resilience argues against an urgent need for rate cuts.

What to Watch

Investors will now focus on upcoming nonfarm payrolls, unemployment and wage growth data to determine whether labor market strength can be sustained. Continued resilience in employment alongside moderating inflation would support the prospect of a gradual easing cycle by the Federal Reserve rather than an aggressive series of interest rate cuts.

💬

WS Investor 07-30-26

US Economy Slows in Second Quarter as Inflation Cools

The U.S. economy grew at a slower pace than expected in the second quarter, while inflation continued to ease, reinforcing signs that economic growth is moderating even as price pressures gradually decline.

Gross domestic product expanded at an annualized rate of 1.5% in the second quarter, below both the 2.1% market expectation and the 2.1% growth recorded in the first quarter. The weaker reading points to slower economic momentum amid a still-restrictive interest rate environment.

Inflation Continues to Moderate

The Federal Reserve's preferred inflation gauge also showed further improvement. The headline PCE Price Index fell 0.1% month-over-month in June, matching expectations and reversing the 0.5% increase recorded in May. On an annual basis, PCE inflation slowed to 3.7%, in line with forecasts and down from 4.1% previously.

The softer inflation data suggest price pressures continue to ease, although inflation remains above the Federal Reserve's long-term target.

Markets Focus on Fed Outlook

The combination of slower economic growth and cooling inflation may strengthen expectations that the Federal Reserve will have greater room to ease monetary policy if inflation continues trending lower. However, policymakers are likely to seek additional evidence that inflation is moving sustainably toward target before making significant policy adjustments.

What to Watch

Investors will now turn their attention to upcoming labor market and inflation reports for further confirmation of the economy's trajectory. Whether inflation continues to cool without a sharper slowdown in economic activity will remain the key factor shaping expectations for future Federal Reserve interest rate decisions.

💬

WS Investor 07-30-26

Fed Holds Interest Rates Steady at 3.75% as Markets Await Warsh’s Guidance

The U.S. Federal Reserve left its benchmark interest rate unchanged at 3.75% on Wednesday, matching market expectations and marking another meeting in which policymakers opted to keep monetary policy steady.

The decision was anticipated, with economists widely expecting the federal funds rate to remain at 3.75%, unchanged from the previous meeting. As a result, investors are now shifting their attention away from the decision itself and toward the Federal Reserve’s policy statement and Fed Chair Kevin Warsh’s remarks for clues about the future path of interest rates.

💬

WS News 07-29-26

The U.S. Energy Information Administration (EIA) reported that crude oil inventories fell by 7.17 million barrels last week, far exceeding market expectations for a 700,000-barrel decline. The previous week's report had shown a build of 2.01 million barrels.

Meanwhile, inventories at the Cushing, Oklahoma delivery hub also declined by 771,000 barrels, following a 674,000-barrel draw in the previous week. Cushing is the primary delivery point for WTI crude futures, and falling inventories there are typically viewed as supportive for oil prices.

The larger-than-expected nationwide inventory draw suggests refinery activity and end-user demand remain resilient despite concerns about global economic growth. The continued decline at Cushing also indicates tightening physical crude supplies in a key U.S. storage hub.

💬

The Investor 07-29-26

07-30-26European Investor

07-29-26WS News

07-28-26WS News

07-24-26WS News

S&P 500

💬

European Investor 08-04-26

💬

The Investor 07-31-26

💬

WS Investor 07-30-26

US Markets Mixed on Tuesday as Dow Climbs While Tech Stocks Weigh on Nasdaq

U.S. stocks traded mixed on Tuesday, with investors rotating away from technology shares while buying more defensive and cyclical names. The Dow Jones Industrial Average outperformed the broader market, gaining 0.68%, while the S&P 500 slipped 0.20%. The Nasdaq Composite lagged, falling 1.05% as weakness in large-cap technology stocks pressured the index.

The divergence between the major indexes suggests investors are becoming more selective following the strong rally in AI and semiconductor stocks over recent months. Profit-taking in technology names weighed on the Nasdaq, while strength in industrial, financial, healthcare, and other value-oriented sectors helped lift the Dow into positive territory.

Technology remained the primary drag on the broader market, with investors trimming exposure ahead of another busy stretch of corporate earnings. Several AI-related and semiconductor companies have reported strong results, but elevated valuations continue to leave little room for disappointment, leading to increased volatility across the sector.

Meanwhile, the Dow’s advance reflected continued interest in companies with more stable earnings profiles. Investors appeared willing to rotate into sectors viewed as less sensitive to lofty growth expectations while still maintaining exposure to the broader U.S. economy.

The mixed session also comes as markets continue to digest the latest earnings releases and assess the outlook for corporate profits through the remainder of 2026. With many companies either raising or reaffirming guidance, stock-specific reactions have become a more important driver than broader macroeconomic themes.

Looking ahead, investors will remain focused on upcoming earnings reports from major technology companies, additional economic data, and any signals that could influence expectations for Federal Reserve policy. Whether the recent rotation away from high-growth technology stocks continues will likely determine the near-term direction of both the Nasdaq and the broader market.

💬

WS News 07-28-26

S&P 500 Sector Performance Today: Communication Services Lead While Technology and Energy Weigh on the Market

The S&P 500 traded little changed on Monday, edging up just 0.02% in early afternoon trading as investors rotated between sectors ahead of a busy week featuring the Federal Reserve's policy decision, major technology earnings, and key U.S. economic data. Broader market sentiment was supported by easing geopolitical tensions following the pause in hostilities between the U.S. and Iran, although weakness in semiconductors and energy stocks limited gains.

Communication Services emerged as the market's strongest-performing sector, gaining 2.06%. The advance was driven by strength in large-cap names such as Alphabet, while investors also positioned ahead of this week's earnings from several technology and internet giants. Consumer Staples followed with a 1.29% gain, reflecting continued demand for defensive stocks, while Financials (+0.88%) and Health Care (+0.87%) also outperformed as investors favored companies reporting solid quarterly earnings.

Consumer Discretionary added 0.75%, supported by improving risk appetite and lower oil prices, which tend to benefit retailers, travel companies, and other consumer-focused businesses. Materials posted a modest 0.20% gain as commodity markets remained relatively stable.

On the downside, Information Technology was the weakest major sector, falling 1.09%. The decline was largely driven by renewed selling pressure in semiconductor stocks following concerns over China's rapidly advancing domestic chip industry and the blockbuster debut of memory chipmaker CXMT. Nvidia, AMD, ASML and several other chip-related companies remained under pressure despite broader market resilience.

Energy shares dropped 1.61%, making the sector the second-worst performer of the day. The decline followed a sharp fall in crude oil prices after the U.S. and Iran paused hostilities, easing concerns over potential supply disruptions in the Middle East. Lower oil prices weighed on major oil producers while boosting sectors that benefit from reduced fuel costs.

Overall, today's sector performance highlights a market that remains balanced between optimism over easing geopolitical risks and caution surrounding the technology sector. Investors are now turning their attention to this week's Federal Reserve meeting and earnings reports from several mega-cap technology companies, which are likely to determine the market's direction over the coming days.

💬

European Investor 07-27-26

U.S. Stock Futures Advance as Earnings Optimism and Middle East De-escalation Lift Sentiment

U.S. stock futures traded higher as investors looked ahead to another busy week of corporate earnings while welcoming signs of easing geopolitical tensions in the Middle East.

Nasdaq futures led the gains, rising 1.19%, while S&P 500 futures added 0.63% and Dow futures advanced 0.48%. The stronger performance in Nasdaq futures reflected continued optimism toward technology and artificial intelligence-related stocks.

Investor sentiment has been supported by a strong start to the second-quarter earnings season. Major U.S. banks, including JPMorgan Chase, Goldman Sachs, Citigroup, and Wells Fargo, reported better-than-expected quarterly results, highlighting resilient consumer activity, robust investment banking fees, and strong trading revenue despite a mixed macroeconomic backdrop.

Markets also continue to benefit from last week’s softer-than-expected U.S. inflation data, which strengthened expectations that the Federal Reserve could begin lowering interest rates later this year. Lower borrowing costs would likely provide additional support for equity valuations, particularly in growth-oriented sectors.

Geopolitical developments also remain in focus. Investor sentiment improved after the United States halted its military attacks on Iran, reducing concerns that the conflict could escalate into a broader regional confrontation. The de-escalation has helped ease fears over global energy supplies, contributing to a pullback in oil prices from last week’s highs and supporting broader risk appetite.

As U.S. cash markets prepare to reopen later on Monday, investors will closely monitor another wave of corporate earnings, particularly from technology and industrial companies, along with any new developments on U.S. trade policy, Federal Reserve expectations, and geopolitical events that could influence market direction.

💬

WS News 07-27-26

U.S. Stocks Mixed as Softer Inflation Boosts Tech While Dow Lags

U.S. stocks traded mixed in early trading on Tuesday as investors reacted to a softer-than-expected June inflation report that strengthened expectations for Federal Reserve interest rate cuts.

The Nasdaq gained about 0.8%, supported by technology and growth stocks that typically benefit from lower interest rates. The S&P 500 also moved modestly higher, while the Dow Jones Industrial Average slipped slightly as investors rotated away from some defensive and value-oriented sectors.

Markets welcomed the June CPI report, which showed headline inflation fell 0.4% month over month, while annual inflation slowed to 3.5%. Core inflation also came in below expectations, with monthly core CPI unchanged and annual core inflation easing to 2.6%. The weaker inflation data reinforced expectations that the Federal Reserve could begin easing monetary policy sooner than previously anticipated.

Technology stocks led gains across the broader market as lower interest rate expectations improved the outlook for high-growth companies. Investors also continued to monitor corporate earnings season, with company-specific results driving notable moves across individual stocks.

Meanwhile, geopolitical developments remained in focus. Recent tensions between the United States and Iran continue to be monitored by investors, particularly after the exchange of military strikes over the past week. Although markets have largely shifted their attention back toward economic data and earnings, any renewed escalation could quickly affect risk sentiment and commodity prices.

Investors will continue watching upcoming economic releases, Federal Reserve commentary, and second-quarter earnings reports for further direction as markets assess the outlook for interest rates and corporate profitability.

💬

WS News 07-14-26

Earnings season is about to kick off — 2 charts reveal how it may go

Wall Street is expecting a tranquil earnings season.

(finance.yahoo.com)

💬

WS Investor 07-13-26

Stock market today: Dow rises, S&P 500 and Nasdaq slip as US and Iran exchange fire, oil jumps

Markets were subdued ahead of a busy week for markets, with inflation reports, bank earnings, and geopolitical risk hanging in the balance.

(finance.yahoo.com)

💬

WS Investor 07-13-26

U.S. Markets Trade Mixed as Investors Monitor U.S.-Iran Conflict and Await Earnings Season

U.S. stocks traded mixed on Monday as investors balanced escalating geopolitical tensions in the Middle East against expectations for upcoming corporate earnings and a resilient U.S. economy.

The S&P 500 slipped 0.23%, while the Nasdaq declined 0.88% as technology stocks came under pressure. The Dow Jones Industrial Average outperformed, edging 0.20% higher with support from industrial and defensive shares.

Investor sentiment remained heavily influenced by the latest developments in the U.S.-Iran conflict. Military exchanges between the two countries intensified in recent days, with both sides carrying out missile and drone strikes and uncertainty surrounding shipping through the Strait of Hormuz continuing to fuel concerns over global energy supplies. The renewed escalation has pushed oil prices higher and added to inflation concerns, although markets remain hopeful that the conflict will not significantly disrupt global crude exports.

On the macroeconomic front, investors continued to digest recent data showing a mixed but generally resilient U.S. economy. Last week’s weaker-than-expected nonfarm payrolls and softer services activity reinforced expectations that the Federal Reserve could still ease monetary policy later this year. At the same time, moderating inflation indicators have helped support the broader outlook for risk assets.

The market is also shifting its focus toward the upcoming second-quarter earnings season, with major U.S. banks set to report results next week. Investors will closely watch corporate guidance for signs that earnings growth can continue despite elevated interest rates, geopolitical uncertainty, and higher energy prices.

Although the major indexes remain near record levels, today’s mixed performance reflects a cautious market environment as investors weigh the economic impact of rising geopolitical tensions against a still-solid U.S. economic backdrop. The direction of the U.S.-Iran conflict, oil prices, and the start of earnings season are likely to remain the primary drivers of market sentiment in the coming days.

💬

WS News 07-13-26

08-04-26European Investor

07-31-26The Investor

07-28-26WS News

07-20-26WS News

NYSE:CAT

Caterpillar Stock Rises 5.7% After Cat Financial Reports Strong Q2 Results

Caterpillar (NYSE: CAT) shares gained 5.7% on Tuesday after its financing subsidiary, Cat Financial, reported solid second-quarter results, highlighting continued strength in equipment financing demand, portfolio quality and lending activity.

Cat Financial reported second-quarter revenue of $991 million, up 10% year over year, while profit increased 6% to $145 million. Profit before taxes rose 13% to $206 million, supported by higher average earning assets, although partially offset by a higher provision for credit losses.

Financing Business Shows Continued Strength

Retail new business volume increased 9% year over year to $3.92 billion, reflecting higher financing activity across all customer segments.

The growth in lending suggests continued demand for Caterpillar equipment despite a mixed macroeconomic environment and supports the company's broader equipment sales ecosystem.

Management said the financing business remains focused on providing financial solutions that help Caterpillar customers and dealers invest in new equipment while maintaining disciplined portfolio management.

Credit Quality Remains Healthy

Cat Financial continued to report strong credit performance during the quarter.

Past-due accounts improved to 1.31% from 1.62% a year earlier, while the allowance for credit losses remained stable at 0.84% of finance receivables. Net write-offs increased only modestly to $20 million from $18 million a year ago, indicating that overall portfolio quality remains resilient.

What to Watch

The strong share price reaction suggests investors welcomed the healthy financing trends and stable credit performance, which are often viewed as indicators of underlying demand for Caterpillar equipment. Going forward, investors will monitor global construction and mining activity, equipment demand, financing volumes and credit quality for further signs of strength across Caterpillar's business.

💬

European Investor 08-04-26

Caterpillar Stock Falls 6.5% as Baird Downgrades Rating Despite High Price Target

Caterpillar (NYSE: CAT) shares fell 6.5% on Wednesday after Robert W. Baird downgraded the construction and mining equipment maker to **Neutral** from **Outperform**, while lowering its price target to **$900 from $1,200**.

Although the new $900 target remains above the stock's current trading price of around $786, the downgrade suggests Baird believes Caterpillar's near-term upside has become more limited after its recent performance and amid a more balanced risk-reward profile.

The revised target still implies meaningful upside, but the sharp reduction from the previous $1,200 estimate reflects a more cautious outlook for the company's earnings trajectory and valuation. Investors often react more strongly to rating downgrades than to the absolute price target, particularly for widely followed industrial companies.

The downgrade comes as Caterpillar faces uncertainty surrounding global construction activity, mining capital spending, and infrastructure demand. Investors are also monitoring the impact of slowing economic growth in some regions and the pace of equipment replacement spending by customers.

Despite Wednesday's decline, Caterpillar continues to benefit from a strong competitive position, healthy cash generation, and long-term demand supported by infrastructure investment, energy, and mining projects. However, Baird's more cautious stance indicates that much of these positives may already be reflected in the stock, leading the firm to adopt a more neutral view on future performance.

💬

The Investor 07-29-26

Caterpillar Drops Despite Baird Price Target Increase

Caterpillar (NYSE: CAT) shares fell 5.6% on Friday despite Robert W. Baird raising its price target on the construction and mining equipment manufacturer to *$1,200 from $1,165*, while maintaining an *Outperform* rating.

Baird's higher price target reflects continued confidence in Caterpillar's long-term earnings power, supported by resilient demand for heavy equipment, infrastructure spending, and the company's disciplined capital allocation. The reaffirmed Outperform rating indicates the firm expects Caterpillar to continue outperforming its peers over time.

Despite the bullish analyst update, Caterpillar came under broad selling pressure during Friday's session. However, the increased price target suggests Wall Street remains optimistic that the recent pullback does not alter the company's strong long-term fundamentals and growth outlook.

💬

The Investor 06-27-26

Caterpillar Shares Rise After JPMorgan Raises Price Target to $1,165

Caterpillar (NYSE: CAT) gained 1.3% as investors reacted to a bullish analyst update from JPMorgan. Analyst Tami Zakaria raised her price target on the construction and mining equipment giant to $1,165 from $1,125 while maintaining an Overweight rating.

The higher target reflects growing confidence in Caterpillar's ability to benefit from strong long-term demand across infrastructure, mining, energy, and industrial markets. The company remains one of the most closely watched indicators of global economic activity due to its broad exposure to construction and resource development projects worldwide.

Investor sentiment toward Caterpillar has also been supported by expectations that lower energy prices and easing geopolitical tensions could help improve the outlook for global growth. The recent U.S.-Iran agreement has reduced concerns about potential disruptions to energy markets, while declining oil prices have eased inflation pressures and improved expectations for future interest-rate cuts.

Caterpillar is particularly well-positioned to benefit from continued investment in infrastructure and natural resources. Mining customers continue to invest in equipment to support demand for critical minerals used in artificial intelligence infrastructure, electric vehicles, and renewable energy technologies. At the same time, government-backed infrastructure projects remain a significant source of demand for construction machinery.

The company has also demonstrated strong pricing discipline and operational execution in recent years, helping support margins despite fluctuations in end-market demand. Investors have increasingly focused on Caterpillar's ability to generate cash flow and return capital to shareholders through dividends and share repurchases.

JPMorgan's target increase adds to the constructive outlook surrounding industrial and capital equipment companies, which have benefited from resilient economic conditions and expectations for continued spending on infrastructure and industrial modernization.

The stock's advance suggests investors welcomed the analyst's more optimistic assessment and continue to view Caterpillar as a key beneficiary of long-term industrial investment trends and improving macroeconomic conditions.

💬

WS Investor 06-18-26

Caterpillar Surges 9% as AI Infrastructure Boom and Record Backlog Power Blowout Quarter

Caterpillar shares are up 9% in trading today, as a Q1 2026 earnings report that blew past expectations on every key metric underscored how the AI infrastructure buildout is becoming a powerful new growth engine for the industrial giant.

Revenue rose 22% year-over-year to $17.42 billion, well above the $16.21 billion consensus, while adjusted EPS came in at $5.54, beating the $4.64 estimate by a wide 19% margin. The beat was broad-based: construction segment revenue jumped 38% while the power and energy segment rose 22%, with power equipment benefiting directly from the AI data center infrastructure boom and higher dealer sales lifting construction. (GuruFocus, CNBC)

Sales growth was driven by higher volume of $2.3 billion and favorable price realization of $426 million. On the financing side, Cat Financial delivered solid supporting numbers, with retail new business volume up 8% to $3.19 billion and past dues falling to a historically low 1.39%. (Stock Titan)

Caterpillar raised its annual revenue forecast following the beat, with a record backlog providing management with confidence in continued momentum through the rest of 2026. The company also deployed $5.7 billion in share repurchases and dividends during the quarter alone. (GuruFocus)

💬

WS Investor 04-30-26

Caterpillar Inc. to Announce First-Quarter 2026 Financial Results on April 30

💬

Global Finance News 04-17-26

The Board of Directors of Caterpillar Inc. (NYSE: CAT) decided the quarterly dividend of $1.51 per share of common stock payable May 19, 2026, to shareholders of record at the close of business April 20, 2026.

💬

WS Investor 04-08-26

Caterpillar Inc. (NYSE: CAT) is showcasing expanded AI, autonomy and digital solutions at CONEXPO-CON/AGG 2026 to improve productivity, safety and labor efficiency across construction jobsites.

Key highlights include:

• Broader AI and autonomy capabilities, including the Cat® AI Assistant™ and the first autonomous Cat® CS12 soil compactor
• Enhanced VisionLink™ fleet management, integrating on- and off-highway data through collaboration with Geotab Inc.
• Launch of Cat Compact, a streamlined experience for small and growing contractors
• Refreshed Cat Rentals and upgraded service commitments offering faster parts and repair guarantees

Caterpillar is also displaying new high-horsepower C3.6 and C13D engines and strengthening connected fleet, condition monitoring and aftermarket support solutions.

The company is hosting live demonstrations and global operator and technician competitions, reinforcing its focus on technology-driven jobsite transformation and workforce development.

💬

European Investor 03-03-26

Caterpillar acquires RPMGlobal to expand mining technology portfolio

Caterpillar Inc. has completed the acquisition of RPMGlobal Holdings Limited, strengthening its portfolio of data-driven mining technology and software solutions.

Based in Brisbane, RPMGlobal provides mining software across the value chain, supporting planning, operations and site management through advanced analytics and domain expertise. Caterpillar first announced its agreement to acquire the company in October 2025.

Caterpillar said the deal enhances its strategy to integrate equipment, digital technologies and software to help customers improve mine site performance and operational efficiency. RPMGlobal will continue operating under its existing brand.

The acquisition supports Caterpillar’s Resource Industries segment and its broader focus on scalable, practical mining technology solutions.

Source: Caterpillar press release

💬

Global Finance News 02-18-26

Caterpillar reported fourth-quarter and full-year 2025 results that marked a record year for sales and revenues, supported by strong end-market demand and disciplined execution, even as margins softened compared with the prior year.

In the fourth quarter, sales and revenues rose 18% year over year to a record $19.1 billion. Profit per share was $5.12, down from $5.78 a year earlier, while adjusted profit per share edged up slightly to $5.16. Operating profit margin declined to 13.9%, reflecting lower pricing realization and cost pressures, though volumes remained strong.

For the full year, sales and revenues reached a record $67.6 billion, up 4% from 2024, driven mainly by higher equipment sales volumes. Full-year profit per share was $18.81, with adjusted profit per share of $19.06, both lower than the prior year as margins contracted. Despite this, Caterpillar generated robust enterprise operating cash flow of $11.7 billion and ended 2025 with $10.0 billion in enterprise cash.

The company returned significant capital to shareholders during the year, deploying $7.9 billion for share repurchases and dividends. Management highlighted that Caterpillar closed its centennial year with record sales and a record backlog, positioning the company with strong momentum as it enters the new year and continues to focus on long-term value creation.

💬

WS Investor 01-29-26

07-02-26Global Finance News

06-30-26WS News

05-19-26The Investor

05-13-26The Investor

NASDAQ

💬

European Investor 08-04-26

💬

WS Investor 07-30-26

💬

WS News 07-28-26

Semiconductor Stocks Fall as China's Chip Breakthrough Pressures Nvidia and the AI Sector

Semiconductor stocks came under pressure on Monday, dragging the Nasdaq lower as investors weighed China's rapidly advancing semiconductor industry against the latest developments in the global AI infrastructure race. Nvidia led the sector's decline, falling more than 4%, while weakness spread across AI and memory chipmakers.

The latest catalyst on the AI front came after reports that Nvidia is in talks to provide roughly $250 billion in financing guarantees for OpenAI's massive AI data center project in Ohio. The proposed 10-gigawatt facility would rank among the world's largest AI infrastructure projects, underscoring the enormous capital being committed to artificial intelligence. While the news reinforces long-term demand for AI hardware, it also highlights the rapidly evolving competitive landscape and the unprecedented scale of investment required across the industry.

Investor sentiment was also weighed down by developments in China. ChangXin Memory Technologies (CXMT), China's largest memory chipmaker, surged more than 400% in its Shanghai trading debut following Asia's largest IPO of 2026. The emergence of another major Chinese chipmaker renewed concerns that global competition in memory and AI-related semiconductors will intensify. Those concerns were particularly significant for Nvidia, whose growth opportunities in China have already been constrained by U.S. export restrictions.

The weakness extended across the broader semiconductor sector. Memory-related companies including Sandisk, Micron Technology, Western Digital, and SK Hynix posted notable declines, while ASML, AMD, Intel, Marvell Technology, Super Micro Computer, and Taiwan Semiconductor Manufacturing Co. (TSMC) also traded lower as investors reassessed the industry's competitive outlook.

Despite Monday's selloff, the semiconductor industry's long-term fundamentals remain supported by accelerating AI adoption and record investment in data center infrastructure. However, the combination of elevated valuations, China's rapid technological progress, and an increasingly competitive global landscape prompted investors to lock in profits following the sector's strong rally.

💬

European Investor 07-27-26

💬

WS News 07-27-26

💬

WS News 07-14-26

Stock market today: Dow rises, S&P 500 and Nasdaq slip as US and Iran exchange fire, oil jumps

Markets were subdued ahead of a busy week for markets, with inflation reports, bank earnings, and geopolitical risk hanging in the balance.

(finance.yahoo.com)

💬

WS Investor 07-13-26

💬

WS News 07-13-26

US Stocks Edge Higher as Tech Shares Lead Early Gains

U.S. stocks traded modestly higher in early trading on Thursday, with technology shares helping lift the broader market as investors reacted to a fresh wave of corporate earnings and analyst upgrades.

The S&P 500 gained 0.15%, while the Nasdaq advanced 0.20%, outperforming the major indexes thanks to strength in semiconductor and AI-related stocks. The Dow Jones Industrial Average also moved higher, rising 0.10%.

Semiconductor Stocks Extend AI Rally

Chip equipment makers led the market higher after several positive analyst actions.

Lam Research (NASDAQ: LRCX) surged in premarket trading after Mizuho raised its price target to $400 and reiterated its *Outperform* rating. Applied Materials (NASDAQ: AMAT) also received a higher price target from Mizuho, while Dell Technologies (NYSE: DELL) benefited from Evercore's reaffirmed *Outperform* rating and new $500 price target, adding to optimism surrounding continued AI infrastructure investment.

The gains reflect ongoing confidence that semiconductor capital spending will remain strong as demand for AI processors, advanced memory, and next-generation data center infrastructure continues to expand.

Earnings Drive Individual Stock Moves

Corporate earnings remained a key driver of early trading.

Simply Good Foods (NASDAQ: SMPL) soared after investors welcomed results that exceeded management's expectations despite lower year-over-year earnings, suggesting confidence in the company's turnaround strategy.

On the downside, PepsiCo (NASDAQ: PEP) declined after investors focused on softer underlying earnings growth and continued margin pressure despite higher revenue and reaffirmed full-year guidance. Northern Technologies International (NASDAQ: NTIC) also traded sharply lower after reporting a quarterly loss caused by margin compression from elevated raw material costs.

Investors Await More Earnings and Economic Data

Market participants remain focused on the upcoming earnings season as investors assess whether corporate profits can continue to support record equity valuations. At the same time, traders are monitoring economic data and Federal Reserve expectations for further clues on the outlook for interest rates.

The combination of resilient AI-related technology stocks and mixed earnings reactions across other sectors is helping keep the broader market in positive territory during Thursday's opening session.

💬

The Investor 07-09-26

Nasdaq Leads Wall Street Higher as Technology Stocks Rally Despite Softer U.S. Services Data

U.S. stocks traded mixed on Monday as investors weighed softer-than-expected economic data against continued strength in technology shares. The Nasdaq outperformed, climbing 1.1%, while the S&P 500 gained 0.6%. The Dow Jones Industrial Average lagged the broader market, slipping marginally into negative territory.

Technology stocks led the advance, helping lift both the Nasdaq and the broader market as investors continued rotating into growth-oriented sectors. The rally came despite economic data pointing to a modest cooling in the U.S. services sector.

The ISM Non-Manufacturing PMI edged down to 54.0 in June from 54.5 in May, missing economists' expectations of 54.2. Meanwhile, the S&P Global Services PMI also came in slightly below forecasts at 51.2. Although both readings remained above the 50-point threshold that separates expansion from contraction, they suggested the pace of growth in the services sector moderated during the month.

At the same time, inflation pressures showed further signs of easing. The ISM Non-Manufacturing Prices Index declined sharply to 67.7 from 71.3, indicating that input cost growth slowed, even though price pressures remain elevated.

The combination of softer business activity and moderating inflation reinforced expectations that the Federal Reserve may have greater flexibility on interest rate policy later this year. Investors largely looked past the slightly weaker economic readings, focusing instead on the prospect of a more accommodative monetary environment, which provided support for high-growth technology stocks.

As trading continues, market participants remain focused on upcoming inflation reports and corporate earnings for further direction on the economy and the outlook for U.S. equities.

💬

WS Investor 07-06-26

08-04-26WS News

07-28-26WS News

07-27-26WS News

Dow Jones Industrial

💬

European Investor 08-04-26

💬

WS Investor 07-30-26

💬

WS News 07-28-26

💬

WS News 07-27-26

💬

WS News 07-14-26

💬

WS News 07-13-26

U.S. Markets Rise Despite Sharp Slowdown in Job Growth as Unemployment Falls

U.S. stocks finished higher on Thursday as investors balanced a much weaker-than-expected June jobs report against an unexpected decline in the unemployment rate, with optimism over the economy's resilience outweighing concerns about slowing hiring.

The Dow Jones Industrial Average climbed 0.77%, while the S&P 500 gained 0.54% and the Nasdaq added 0.39%.

The June employment report showed the U.S. economy added just 57,000 nonfarm payrolls, well below economists' expectations of 114,000 and sharply lower than May's revised 129,000. The data pointed to a significant slowdown in hiring and reinforced signs that the labor market is gradually cooling.

However, the unemployment rate unexpectedly fell to 4.2% from 4.3%, while initial jobless claims declined to 215,000 from 216,000 and came in below the 219,000 consensus forecast. The lower unemployment rate and continued strength in weekly jobless claims suggested the labor market remains relatively resilient despite slower job creation.

The mixed employment data leaves the Federal Reserve facing a delicate balancing act. Slower payroll growth supports the case for future interest rate cuts, while the lower unemployment rate reduces the urgency for policymakers to ease monetary policy immediately.

Markets also continued to digest recent comments from Federal Reserve Chair Kevin Warsh, who reiterated this week that inflation remains above the Fed's 2% target and emphasized that future policy decisions will remain data dependent.

Investors will now turn their attention to upcoming inflation reports and additional labor market data for further clues on when the Federal Reserve may begin lowering interest rates.

💬

Global Finance News 07-02-26

U.S. Stocks Trade Mixed as Weak Jobs Data Pressures Tech While Dow Holds Gains

U.S. stocks traded mixed on Wednesday as investors weighed weaker-than-expected private employment data against growing expectations that the Federal Reserve could begin cutting interest rates later this year.

At the time of writing, the Dow Jones Industrial Average rose 80 points, or 0.15%, to 52,399.58. The S&P 500 slipped 0.05% to 7,495.76, while the Nasdaq Composite fell 0.29% to 26,138.87 as technology stocks underperformed.

# Weak ADP Jobs Report Signals Cooling Labor Market

Investor attention centered on the June ADP employment report, which showed U.S. private employers added 98,000 jobs, below economists' expectations of 118,000 and down from May's revised 122,000.

The softer-than-expected reading suggests the labor market is gradually cooling, reinforcing expectations that the Federal Reserve could gain greater confidence to lower interest rates if broader economic data continue to weaken.

Markets are now turning their focus to Friday's official nonfarm payrolls report, which is expected to provide a clearer picture of labor market conditions.

# Technology Stocks Pause After Strong Rally

The Nasdaq lagged the broader market as investors took profits in technology shares following recent record highs.

Despite the modest pullback, AI-related companies and semiconductor stocks have remained among the market's strongest performers in recent weeks, supported by continued earnings optimism and robust investment in artificial intelligence infrastructure.

# Investors Await More Economic Data

In addition to labor market data, investors continue monitoring inflation trends and upcoming Federal Reserve communications for clues on the timing of potential policy easing.

While weaker employment data could support the case for lower interest rates, market participants remain cautious ahead of additional economic releases that could influence the Fed's outlook.

With Wall Street near record levels, investors are balancing optimism over potential monetary policy easing against signs of slowing economic momentum, leaving the major indexes little changed during Wednesday's session.

💬

European Investor 07-01-26

U.S. Stocks Rally as Strong Economic Data and Easing Geopolitical Risks Lift Sentiment

U.S. stocks moved higher on Thursday as investors welcomed a series of encouraging economic reports and continued to benefit from improving geopolitical conditions, pushing major indexes closer to record territory.

The S&P 500 gained 0.79% to 7,479, while the Dow Jones Industrial Average advanced 0.62% to 51,811. The Nasdaq Composite outperformed with a 0.93% rise to 26,263, supported by continued strength in semiconductor and artificial intelligence-related stocks.

Market sentiment was boosted by stronger-than-expected economic data that pointed to a resilient U.S. economy. The Philadelphia Fed Manufacturing Index rose to 10.3 in June, surpassing expectations of 9.8 and rebounding sharply from May's -0.4 reading. The return to expansion territory suggests manufacturing activity is improving despite concerns about slowing growth in some sectors.

Labor market data also remained constructive. Initial jobless claims fell to 226,000 from 230,000 the previous week, indicating layoffs remain limited. While continuing claims rose modestly to 1.81 million, the overall data continued to support the view that the labor market remains healthy and capable of supporting consumer spending.

Investors were further encouraged by signs that inflation pressures may remain manageable. Lower energy prices following the recent U.S.-Iran agreement have reduced concerns about supply disruptions and helped improve the inflation outlook. Brent crude oil has retreated significantly from recent highs, easing pressure on consumers and businesses alike.

At the same time, recent data has suggested that economic growth is moderating rather than contracting. While housing activity has weakened amid elevated borrowing costs, consumer spending remains relatively strong and manufacturing activity has shown renewed momentum. This combination has strengthened hopes that the U.S. economy can achieve a soft landing without slipping into recession.

Technology shares continued to attract buyers as optimism surrounding artificial intelligence investment remained a major market theme. Several semiconductor companies have received bullish analyst updates this week, including Applied Materials, Lam Research, Micron Technology, AMD, Arm Holdings, and KLA, reinforcing expectations that AI infrastructure spending will remain a powerful driver of corporate earnings and capital investment.

Overall, markets appear increasingly confident that economic growth can remain positive while inflation continues to ease. Strong labor market conditions, improving manufacturing activity, resilient consumer demand, and lower geopolitical risks have combined to support risk appetite, helping major U.S. equity indexes extend their advance despite ongoing uncertainty about the timing of future Federal Reserve policy moves.

💬

Global Finance News 06-18-26

U.S. Stocks Suffer Sharp Selloff as Strong Jobs Data and Rate Fears Hit Tech Sector

U.S. markets closed sharply lower on Friday, with the S&P 500 falling 2.64%, the Dow Jones Industrial Average losing 1.35%, and the Nasdaq plunging 4.18% in its worst session since April 2025. The selloff ended a nine-week winning streak for the benchmark index.

The primary catalyst was a stronger-than-expected U.S. employment report. Nonfarm payrolls increased by 172,000 in May, well above expectations, while the unemployment rate held steady at 4.3%. The data reinforced the view that the labor market remains resilient despite higher interest rates and recent economic uncertainty.

While strong economic growth is generally positive, investors interpreted the report as reducing the likelihood of Federal Reserve rate cuts later this year. Markets are now increasingly concerned that persistent inflation and a strong labor market could keep monetary policy restrictive for longer.

Technology and semiconductor stocks led the decline. The AI sector came under particular pressure after disappointing guidance from Broadcom earlier in the week sparked concerns that the pace of AI-related spending growth may be moderating. Major chipmakers including Nvidia, AMD, Intel, Broadcom, Micron and Marvell posted steep losses, dragging the Nasdaq sharply lower.

Investor sentiment was also weighed down by ongoing Middle East tensions and elevated oil-market uncertainty. Disruptions around Iran and the Strait of Hormuz could keep energy prices volatile, potentially adding further inflationary pressure at a time when the Federal Reserve remains focused on price stability.

Despite the sharp decline, major indexes remain significantly higher than a year ago. However, Friday's trading highlighted how sensitive markets have become to economic data that could alter expectations for Federal Reserve policy and the sustainability of the AI-driven market rally.

💬

The Investor 06-06-26

08-04-26European Investor

07-20-26WS News

07-13-26WS News

07-02-26Global Finance News

04-22-26The Investor

NASDAQ:VRTX

Vertex Pharmaceuticals Stock Rises 2.2% After Strong Q2 Results and Higher Revenue Guidance

Vertex Pharmaceuticals (NASDAQ: VRTX) shares rose 2.2% on Tuesday after the biotechnology company reported strong second-quarter results, raised its full-year revenue guidance and highlighted continued progress across both its commercial portfolio and late-stage pipeline.

Second-quarter revenue increased 12% year over year to $3.33 billion, driven by continued strength in its cystic fibrosis (CF) franchise and growing contributions from newer products, including CASGEVY and JOURNAVX. The company also increased its 2026 revenue outlook to $13.1 billion-$13.2 billion from its previous guidance of $12.95 billion-$13.1 billion.

Cystic Fibrosis Business Remains the Growth Engine

Vertex's core CF business continued to deliver solid performance, supported by strong patient demand for ALYFTREK and TRIKAFTA. U.S. revenue increased 11% to $2.06 billion, while international revenue rose 14% to $1.28 billion as ALYFTREK adoption expanded across global markets and CASGEVY infusions continued to grow.

Management expects non-CF products, primarily CASGEVY and the recently launched acute pain treatment JOURNAVX, to generate at least $500 million in revenue during 2026, reflecting the company's ongoing diversification beyond its traditional CF franchise.

Pipeline Expansion and Crinetics Acquisition Strengthen Outlook

Vertex continued advancing its pipeline, with povetacicept remaining on track for a November 30 PDUFA date. The company also announced its planned acquisition of Crinetics Pharmaceuticals, expected to close during the third quarter, adding rare endocrine diseases as a fifth major therapeutic pillar.

CEO Reshma Kewalramani said the company's expanding commercial portfolio and pipeline position Vertex to deliver additional innovative therapies while creating long-term shareholder value.

Strong Balance Sheet Supports Growth Strategy

Vertex ended the quarter with $13.6 billion in cash, cash equivalents and marketable securities, up from $12.3 billion at year-end, supported by strong operating cash flow. The company continued investing in commercial launches and pipeline development while repurchasing shares under its existing buyback program.

What to Watch

Investors will be watching the continued global rollout of ALYFTREK, commercial adoption of CASGEVY and JOURNAVX, the upcoming FDA decision on povetacicept, and the expected completion of the Crinetics acquisition. Markets will also monitor whether Vertex can continue expanding beyond cystic fibrosis while maintaining its strong revenue growth and profitability.

💬

European Investor 08-04-26

Vertex Pharmaceuticals Slips 1% in Pre-Market After Solid Q1 Results

May 5, 2026

Vertex Pharmaceuticals (Nasdaq: VRTX) edged lower by about 1% in Tuesday's pre-market session following the release of its first quarter 2026 earnings report after Monday's close. The modest decline appears to reflect a market that found the results solid but not surprising — a steady, well-managed business delivering in line with expectations rather than a dramatic beat.

Q1 by the Numbers

Total revenue came in at $2.99 billion, an 8% increase compared to the first quarter of 2025. Growth was driven by the continued strength of the company's cystic fibrosis portfolio alongside a meaningful contribution from newer products. In the U.S., revenue rose 7% to $1.78 billion, supported by strong demand for ALYFTREK, higher net prices across CF therapies, and early contributions from CASGEVY and JOURNAVX. Outside the U.S., revenue grew 9% to $1.21 billion, helped in part by favorable foreign exchange movements.

CEO Reshma Kewalramani highlighted that CASGEVY and JOURNAVX together accounted for more than 25% of the company's quarterly growth, calling it a sign of a revenue base that is becoming increasingly diversified beyond cystic fibrosis.

GAAP net income for the quarter was $1.0 billion, up sharply from $646 million in the same period a year ago — though that comparison is flattered by a $379 million intangible asset impairment charge that weighed on Q1 2025 results. Non-GAAP net income came in at $1.1 billion, up $93 million year-over-year. Cash and marketable securities grew to $13.0 billion as of March 31, compared to $12.3 billion at the end of 2025.

Guidance Unchanged

Vertex reiterated its full year 2026 financial guidance without revision, targeting total revenue of $12.95 billion to $13.1 billion. Non-CF product revenue is expected to reach at least $500 million. The company maintained its combined non-GAAP R&D and SG&A expense guidance of $5.65 to $5.75 billion and a non-GAAP effective tax rate of 19.5% to 20.5%.

The unchanged guidance may be one reason the stock is seeing mild selling pressure. In a market that rewards upward revisions, reiterating prior forecasts — even strong ones — can read as a lack of near-term catalysts.

Pipeline Progress

On the pipeline front, Vertex completed a rolling BLA submission for povetacicept, seeking U.S. accelerated approval in IgA nephropathy following positive Phase 3 interim data. The company also initiated a Phase 3 study in primary membranous nephropathy and a Phase 2 study in generalized myasthenia gravis — moves that signal the company is serious about building a fourth franchise in nephrology alongside CF, gene therapy, and pain.

The FDA recently approved label extensions for both ALYFTREK and TRIKAFTA, making approximately 800 more CF patients in the U.S. eligible for treatment for the first time. Additionally, Vertex submitted for U.S. approval of CASGEVY in children ages 5 to 11 with sickle cell disease or transfusion-dependent beta thalassemia, receiving a Commissioner's National Priority Voucher indicating an accelerated review timeline.

JOURNAVX, the company's first-in-class non-opioid pain medication launched in March 2025, surpassed one million total prescriptions filled, with more than 350,000 filled in Q1 alone. Vertex recorded $29 million in JOURNAVX revenue for the quarter and recently secured Medicare Part D coverage adding approximately 10 million lives.

The Bigger Picture

Vertex is not a company in crisis — far from it. It has a dominant position in cystic fibrosis, a growing gene therapy business, and a pain franchise gaining meaningful traction. The mild pre-market dip likely reflects the absence of a positive guidance revision rather than any fundamental concern. For long-term investors, the pipeline news — particularly around povetacicept in nephrology — may prove to be the most significant takeaway from the quarter.

💬

The Investor 05-05-26

Vertex to Announce First Quarter 2026 Financial Results on May 4th

💬

Global Finance News 04-07-26

Vertex Pharmaceuticals reported new Phase 4 study data showing its non-opioid pain drug JOURNAVX enabled opioid-free recovery in most patients following aesthetic and reconstructive surgeries.

In the study of 99 patients, 90.9% remained opioid-free for up to 14 days after surgery when JOURNAVX was used as part of multimodal pain treatment with medicines such as acetaminophen and ibuprofen. About 90.7% of patients rated the treatment’s effectiveness as excellent, very good, or good.

The company said the results highlight the drug’s potential to support opioid-free pain management after surgery. The findings will be presented at the American Academy of Pain Medicine’s PainConnect 2026 meeting.

Business Wire

💬

Global Finance News 03-06-26

Vertex Pharmaceuticals reported strong fourth quarter and full-year 2025 results, supported by growth in its cystic fibrosis (CF) franchise and contributions from newer products.

In Q4 2025, total revenue rose 10% year over year to $3.19 billion. U.S. revenue increased 12% to $2.06 billion, driven by strong CF demand, including ALYFTREK, and contributions from CASGEVY and JOURNAVX. International revenue grew 5% to $1.13 billion. GAAP net income was $1.2 billion, up from $913 million in Q4 2024.

For full-year 2025, revenue increased 9% to $12.0 billion, with U.S. revenue up 13% to $7.55 billion and international revenue up 3% to $4.45 billion. GAAP net income reached $4.0 billion, compared to a net loss in 2024, reflecting higher product revenue and the absence of large Alpine acquisition-related charges from the prior year. Vertex ended 2025 with $12.3 billion in cash and marketable securities.

For 2026, the company expects total revenue of $12.95–$13.1 billion, including at least $500 million from non-CF products such as CASGEVY and JOURNAVX. Vertex also remains on track to complete a BLA filing for U.S. accelerated approval of povetacicept in IgA nephropathy in the first half of 2026.

Business Wire

💬

WS Investor 02-13-26

Vertex Unveils First CASGEVY Data in Children 5–11 and Plans Global Regulatory Filings for 2026

Vertex presented the first clinical data showing that CASGEVY, its CRISPR-based gene-editing therapy, produced strong and durable benefits in children ages 5–11 with severe sickle cell disease or transfusion-dependent beta thalassemia. All evaluable young patients met key endpoints: sickle cell patients remained free of vaso-occlusive crises for at least 12 months, and thalassemia patients achieved transfusion independence. Safety findings were consistent with expectations from myeloablative conditioning and transplant. Longer-term results in patients 12 and older continued to show sustained remission and transfusion independence. Vertex plans to begin global regulatory submissions for the 5–11 age group in the first half of 2026.

💬

Global Finance News 12-07-25

Vertex delivers 11% revenue growth in Q3, raises 2025 revenue outlook to up to $12 billion

Vertex Pharmaceuticals (Nasdaq: VRTX) reported third-quarter 2025 revenue of $3.08 billion, up 11% year over year, driven by continued strength in cystic fibrosis (CF) therapies, including ALYFTREK, and early sales from new launches CASGEVY and JOURNAVX. U.S. revenue grew 15% to $1.98 billion, while international revenue rose 4% to $1.10 billion. GAAP net income reached $1.1 billion, and non-GAAP net income was $1.2 billion, reflecting strong product demand and disciplined expense management.

The company refined its full-year 2025 guidance, now expecting total revenue of $11.9–$12.0 billion and combined non-GAAP R&D, AIPR&D, and SG&A expenses of $5.0–$5.1 billion. Vertex also lowered its non-GAAP effective tax rate forecast to 17–18% due to one-time R&D tax benefits.

CEO Dr. Reshma Kewalramani highlighted progress in the R&D pipeline, including five programs in pivotal development, full enrollment in the Phase 3 IgAN trial for povetacicept, and plans to submit the first module of its Biologics License Application to the FDA by year-end. Vertex ended the quarter with $12 billion in cash and marketable securities, up from $11.2 billion at the end of 2024.

💬

The Investor 11-04-25

Vertex Highlights New Data on Cystic Fibrosis Treatments at NACFC 2025

Vertex Pharmaceuticals (Nasdaq: VRTX) presented new clinical data at the North American Cystic Fibrosis Conference (NACFC) in Seattle, showcasing the benefits of its CFTR modulators, including the latest therapy ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor).

The studies show that reductions in sweat chloride (SwCl) — a marker of improved CFTR function — correlate with better outcomes in cystic fibrosis (CF) patients, particularly children. In Phase 3 trials, ALYFTREK achieved greater sweat chloride reduction than TRIKAFTA, suggesting stronger potential improvements in lung function and quality of life.

Post-hoc analyses found fewer pulmonary exacerbations and hospitalizations for patients treated with ALYFTREK compared to TRIKAFTA. Data also confirmed that starting modulator therapy earlier in childhood yields broader clinical benefits, including better lung health and nutrition.

💬

The Investor 10-23-25

Vertex Pharmaceuticals announced major progress in its kidney disease pipeline, including FDA Breakthrough Therapy Designation for povetacicept in IgA nephropathy with potential U.S. accelerated approval in H1 2026, completion of enrollment for the interim cohort of the Phase 2/3 AMPLITUDE trial of inaxaplin in APOL1-mediated kidney disease (also targeting accelerated approval), and initiation of a Phase 2 proof-of-concept study for VX-407 in autosomal dominant polycystic kidney disease, underscoring its push to deliver first-in-class therapies for serious kidney conditions.

💬

The Investor 09-25-25

Vertex Pharmaceuticals has partnered with basketball world champion Jayson Tatum to raise awareness of JOURNAVX, its newly approved non-opioid medicine for moderate-to-severe acute pain. After rupturing his Achilles tendon during the 2025 playoffs, Tatum turned to JOURNAVX as an alternative to opioids, citing its effectiveness in managing his post-surgical pain without the side effects he experienced from traditional treatments. The FDA approved JOURNAVX in January 2025, making it the first new class of acute pain medicine in over two decades. By sharing his recovery story, Tatum hopes to encourage others to explore non-opioid options, while Vertex underscores its commitment to offering safer alternatives in pain management.

💬

The Investor 09-23-25

02-24-25WS News

US Funds

Nasdaq Slides as Chip Sell-Off Accelerates, Dragging Semiconductor ETFs and AI Leaders Lower

The Nasdaq came under heavy selling pressure on Thursday after a relatively resilient start to the session, with semiconductor stocks leading a broad technology retreat. While the Dow Jones remained in positive territory, the Nasdaq fell more than 1.4% as investors aggressively sold chipmakers following their exceptional first-half rally.

The weakness was widespread across the semiconductor industry. Micron Technology (MU) dropped more than 7%, while SanDisk (SNDK) plunged over 15%, extending a sharp pullback that began after both companies posted massive year-to-date gains. Other major chip names, including Nvidia (NVDA), Advanced Micro Devices (AMD), Broadcom (AVGO) and Western Digital (WDC) also traded lower as investors continued rotating out of AI infrastructure stocks.

The sell-off was equally visible in sector exchange-traded funds. The iShares Semiconductor ETF (SOXX) fell roughly 7%, while the VanEck Semiconductor ETF (SMH) lost nearly 6%, highlighting broad-based weakness rather than company-specific concerns. The decline suggests investors are taking profits across the semiconductor sector after one of its strongest first-half performances on record.

Analysts point to a combination of factors behind the retreat, including profit-taking after extraordinary gains, concerns that AI-related chip valuations had become stretched, and signs that investors are rotating toward other parts of the technology sector. Recent reports suggesting cloud providers could optimize AI infrastructure spending have also fueled concerns that the pace of semiconductor demand growth may moderate, even as the long-term AI investment theme remains intact.

Despite Thursday’s sharp decline, many Wall Street analysts continue to view the move as a healthy correction rather than a change in the industry’s long-term outlook, arguing that AI-driven demand for advanced chips and memory products remains robust over the coming years.

💬

WS News 07-02-26

💬

The Investor 03-11-26

State Street Investment Management launched the State Street IG Public & Private ABS ETF (PRAB), an actively managed exchange-traded fund designed to give investors broader exposure to investment-grade asset-backed securities across both public and private markets.

The fund invests in securities such as collateralized loan obligations (CLOs) and residential and commercial mortgage-backed securities, aiming to provide diversified income opportunities and potentially higher yields compared with corporate bonds of similar risk.

State Street said the ETF responds to growing investor demand for access to the global asset-backed finance market, which exceeds $20 trillion but remains underrepresented in traditional bond portfolios.
Business Wire

💬

The Investor 03-11-26

State Street Investment Management has expanded its MyIncome ETF lineup with the launch of five actively managed high yield corporate bond target maturity ETFs, adding to what it calls the industry’s first actively managed corporate target maturity ETF suite.

The new funds — My2027 (MYHA), My2028 (MYHB), My2029 (MYHC), My2030 (MYHD) and My2031 (MYHE) High Yield Corporate Bond ETFs — provide exposure to high yield bonds with matching maturity years from 2027 through 2031. The ETFs are designed to help investors build bond ladders that manage interest rate risk while offering predictable income and liquidity.

Managed by the firm’s fixed income team, the funds aim to maximize yield while preserving capital and managing liquidity, sector and issuer concentration risks. Each ETF is structured to distribute remaining principal and liquidate around December 15 of its respective maturity year. As of January 31, 2026, assets under management in the MyIncome suite totaled $298 million.

Source:Business Wire

💬

Global Finance News 02-28-26

Sector Momentum Favors Defense; QQQ Yet To Break; Split NDX Breadth

The stock market is clearly in defensive mode but QQQ is still holding up, and its long-term breadth still hasn't turned bearish. Arthur Hill's analysis identifies the key levels to watch.

(articles.stockcharts.com)

💬

The Investor 02-20-26

State Street Investment Management has launched the **State Street Prime Money Market ETF (MMK)**, an actively managed ETF designed to provide flexible, transparent, and cost-effective cash management.

The ETF aims to maximize current income while preserving capital and liquidity, investing in short-term, high-quality debt instruments such as U.S. government securities, certificates of deposit, commercial paper, asset-backed securities, mortgage-related securities, and repurchase agreements.

With an expense ratio of **18 basis points**, MMK is among the lowest-cost active prime money market ETFs in the U.S. As of December 31, 2025, State Street’s cash team managed approximately **$599.55 billion** in assets.

Source: Business Wire.

💬

European Investor 02-12-26

VantagePoint A.I. Asset of the Week iShares Silver Trust ($SLV) - VantagePoint $SLV

This week's ai asset spotlight is the iShares Silver Trust ($SLV) On December 3, 2025, we put $SLV front and center as our Asset of the Week and made one thing crystal clear: silver was no

(vantagepointsoftware.com)

💬

WS Investor 01-15-26

I collected my first dividend from the FDVV ETF this week. It was not much—just $12—but it felt good to see the portfolio start to generate cash. Over time, I expect these payments to grow.

I am also spending time researching QQQI. It is a relatively new ETF and clearly carries more risk, especially since it focuses on large technology companies that may be somewhat overvalued right now. Still, I plan to allocate a small portion of my portfolio to it. The annual yield of around 13% is attractive, and I believe the tech and AI rally is likely to continue for at least another couple of years. If that plays out, QQQI could contribute meaningfully to overall returns.

💬

A Dividend Journey 12-26-25

Blackrock multi asset income monthly commentary ...

(blackrock.com)

💬

The Investor 12-21-25

State Street launches lowest-cost leveraged loan ETF in the U.S.

State Street Investment Management introduced the State Street SPDR S&P Leveraged Loan ETF (LVLN), giving investors broad, index-based exposure to the expanding leveraged loan market. With a 0.40 percent gross expense ratio, LVLN is now the lowest-cost leveraged loan ETF available in the U.S., according to Bloomberg data as of November 18, 2025.

The fund tracks the S&P USD Select Leveraged Loan Index, which includes U.S. dollar–denominated loans of at least 500 million dollars and applies issuer, facility and industry caps for diversified coverage. State Street says demand for leveraged loans continues to grow as investors seek income and low correlation to Treasuries and investment-grade corporate bonds.

The launch expands State Street’s fixed-income ETF lineup to include both active and index strategies targeting the rapidly growing loan segment.

💬

The Investor 11-18-25

08-04-26European Investor

08-03-26WS News

07-27-26European Investor

07-17-26WS News

NYSE:MRK

Merck Stock Edges Higher as Strong Product Growth Offsets Acquisition Charge

Merck (NYSE: MRK) shares rose 0.54% on Tuesday after the pharmaceutical company reported solid second-quarter revenue growth, raised its full-year sales outlook and highlighted multiple regulatory and clinical milestones, despite posting a quarterly loss due to a one-time acquisition-related charge.

Second-quarter worldwide sales increased 5% year over year to $16.6 billion, driven by continued strength in oncology, animal health and recently launched products. The company reported a GAAP loss per share of $0.54 and a non-GAAP loss per share of $0.13, both primarily reflecting a $2.31 per share charge related to the acquisition of Terns Pharmaceuticals.

Oncology and New Product Launches Drive Revenue Growth

Merck's flagship cancer franchise remained the company's largest growth engine.

KEYTRUDA and the newly launched KEYTRUDA QLEX generated combined sales of $8.4 billion, up 5% from a year earlier, with KEYTRUDA QLEX contributing $463 million during its initial launch period.

WINREVAIR continued its rapid commercial expansion, with sales jumping 75% year over year to $588 million, while Animal Health revenue increased 8% to $1.8 billion, providing additional support for overall growth.

Pipeline Momentum and Higher Guidance

Beyond commercial performance, Merck reported several important pipeline achievements during the quarter.

The FDA approved LIPFENDRA, the first once-daily oral PCSK9 inhibitor for lowering LDL cholesterol, while the company also announced positive clinical data for its oncology and HIV programs, including a Phase 3 study evaluating a once-weekly oral HIV treatment developed with Gilead.

Reflecting continued business momentum, Merck narrowed and raised its full-year 2026 revenue guidance to between $66.3 billion and $67.3 billion. The company now expects non-GAAP EPS of $2.66 to $2.76, including the financial impact of the Terns acquisition.

What to Watch

Despite the acquisition-related accounting charge, investors appeared encouraged by Merck's underlying operating performance, growing contribution from recently launched medicines and continued pipeline progress. Going forward, markets will monitor the commercial rollout of KEYTRUDA QLEX and LIPFENDRA, continued growth of WINREVAIR, and additional regulatory and clinical milestones expected across Merck's expanding pipeline.

💬

European Investor 08-04-26

Merck (MRK) Stock Slips Despite Scotiabank Raising Price Target

Merck (NYSE: MRK) shares traded modestly lower on Tuesday despite receiving a higher price target from Scotiabank, as investors remained cautious toward the pharmaceutical giant.

Scotiabank raised its price target to $155 from $136 while maintaining its Sector Outperform rating, signaling continued confidence in Merck's long-term growth prospects despite the stock's recent weakness.

# Scotiabank Sees Greater Upside

The higher price target reflects Scotiabank's positive outlook for Merck's diversified pharmaceutical portfolio and its ability to deliver long-term earnings growth.

The firm remains optimistic about Merck's pipeline, oncology franchise, and ongoing efforts to diversify revenue sources ahead of future patent expirations for key products.

# Long-Term Fundamentals Remain Intact

Merck continues to invest heavily in expanding its product portfolio through internal research and strategic acquisitions while advancing multiple late-stage pipeline candidates.

Analysts expect new product launches and pipeline development to play an increasingly important role in supporting future revenue growth as the company prepares for the eventual loss of exclusivity on some of its blockbuster therapies.

# Why MRK Stock Was Lower

Although Scotiabank raised its valuation target, the positive analyst action was not enough to offset broader selling pressure in the stock.

Investors appeared to remain focused on near-term industry challenges and long-term patent expiration concerns rather than the improved valuation.

Still, Scotiabank's decision to raise its price target while maintaining a Sector Outperform rating reinforces Wall Street's confidence in Merck's long-term earnings potential despite Tuesday's modest decline.

💬

Global Finance News 06-30-26

Merck & Co., Inc. reported fourth-quarter and full-year 2025 results showing resilient performance driven by oncology and animal health, while highlighting significant progress across its late-stage pipeline.

Fourth-quarter worldwide sales rose 5% to $16.4 billion, with GAAP EPS of $1.19 and non-GAAP EPS of $2.04. For full-year 2025, Merck generated $65.0 billion in worldwide sales, up 1% year over year, supported by 7% growth in KEYTRUDA/KEYTRUDA QLEX sales to $31.7 billion, $1.4 billion in WINREVAIR sales, and strong Animal Health growth of 8%. These gains were partly offset by a sharp decline in GARDASIL/GARDASIL 9 sales.

During 2025, Merck reported positive results from 18 Phase 3 trials, expanded its pipeline through acquisitions and licensing deals, and received FDA National Priority Vouchers for key late-stage assets. Looking ahead, the company expects 2026 worldwide sales of $65.5–$67.0 billion and non-GAAP EPS of $5.00–$5.15, reflecting a one-time charge related to the Cidara Therapeutics acquisition.

Source: Merck & Co., Inc. press release

💬

WS Investor 02-03-26

Merck Launches ChemiSphere App to Streamline Laboratory Data Access

Merck KGaA has launched the ChemiSphere app, a digital tool that allows scientists to instantly access product documentation and quality data by scanning 2D barcodes on lab products. Built on Merck’s M-Trust platform, the app aims to reduce manual data entry, improve data integrity, and boost efficiency in laboratory workflows.

💬

WS Investor 12-22-25

Merck Reports Solid Q3 Results and Raises 2025 Outlook on Strong Oncology and New Product Performance

Merck & Co. (NYSE: MRK) posted third-quarter 2025 revenue of $17.3 billion, up 4% year over year, driven by continued strength in oncology and animal health. KEYTRUDA sales rose 10% to $8.1 billion, WINREVAIR surged 141% to $360 million, and CAPVAXIVE contributed $244 million in its launch quarter. GAAP EPS climbed 87% to $2.32, while non-GAAP EPS increased 64% to $2.58. The company raised its full-year sales outlook to $64.5–$65.0 billion and narrowed non-GAAP EPS guidance to $8.93–$8.98.

Merck highlighted major milestones, including FDA approval of subcutaneous KEYTRUDA QLEX, positive Phase 3 results for Enlicitide Decanoate in hypercholesterolemia, and the completion of its acquisition of Verona Pharma, strengthening its respiratory portfolio.

💬

Global Finance News 10-30-25

Merck Selects Veeva Vault CRM to Support Major Launch Period

Veeva Systems (NYSE: VEEV) announced on July 21, 2025, that Merck (NYSE: MRK) has committed to adopting Veeva Vault CRM as its commercial execution platform. This move supports Merck’s entry into one of the most significant launch phases in its history, spanning multiple therapeutic areas and treatment modalities.

The partnership expands Merck’s longstanding relationship with Veeva, aiming to boost global commercial capabilities through Vault CRM’s personal and digital engagement tools and compliance-tailored features. Merck’s EVP and CIO Dave Williams highlighted the role of Vault CRM in enhancing customer success and execution.

Vault CRM is part of the broader Vault CRM Suite, designed for the life sciences industry’s complex regional and compliance needs.

💬

European Investor 07-23-25

Is Merck & Co., Inc. (MRK) the Most Reliable Dividend Stock to Buy According to Hedge Funds?

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other dividend stocks. The year 2024 proved favorable for dividends, even though the Dividend Aristocrats Index lagged behind […]

(finance.yahoo.com)

💬

Global Finance News 01-15-25

08-04-26European Investor

COINBASE:BTCUSD

Live updates: Bitcoin holds $62,600 as the Iran conflict reignites and CPI looms

Trump reinstated the Hormuz blockade, sending oil higher and rate-hike bets up, reversing the peace trade that helped bitcoin recover in early July. Today's inflation print is the next test.

(coindesk.com)

💬

Global Finance News 07-14-26

Bitcoin (BTC) Falls 1.2% as Cautious Sentiment Keeps Price Below $60,000

Bitcoin (BTC) traded lower on Tuesday, extending its recent weakness as investors remained cautious despite improving sentiment across global equity markets.

At the time of writing, Bitcoin was trading at $59,273.83, down 1.2% over the past 24 hours after failing to reclaim the key $60,000 level.

# Bitcoin Remains Under Pressure

The world's largest cryptocurrency briefly approached $60,000 but failed to sustain momentum, with sellers pushing prices lower as traders continued to assess the outlook for monetary policy and institutional demand.

Unlike U.S. equities, which benefited from easing geopolitical tensions following the U.S.-Iran ceasefire, Bitcoin did not participate in the broader risk-on move and has remained under pressure in recent weeks.

# Macro Headwinds Continue to Weigh

Analysts point to several factors limiting Bitcoin's recovery, including uncertainty surrounding the Federal Reserve's interest-rate outlook, persistent outflows from crypto investment products, and weaker overall demand for digital assets. Recent reports have also highlighted concerns over potential additional Bitcoin supply entering the market from large holders.

# What Investors Are Watching

Market participants continue to monitor:

* Federal Reserve policy expectations.
* Institutional demand for Bitcoin.
* ETF flows and broader crypto market sentiment.
* Key technical support around the $58,000–$60,000 range.

While long-term adoption trends remain intact, Bitcoin has struggled to regain upward momentum in 2026. Until macroeconomic conditions improve or institutional buying strengthens, the cryptocurrency is likely to remain sensitive to interest-rate expectations and shifts in investor risk appetite.

💬

WS Investor 06-30-26

Bitcoin Holds Above $60,000 as Buyers Return After Sharp Selloff

Bitcoin (BTC) traded around *$60,360* on Saturday, gaining nearly 2% over the past 24 hours as the cryptocurrency rebounded from this week's sharp decline. The recovery comes after Bitcoin briefly slipped below the psychologically important $60,000 level, with buyers stepping in as market sentiment stabilized.

Why is Bitcoin rising?

The latest bounce appears to be driven by bargain hunting following several days of heavy selling that pushed Bitcoin to its lowest levels in months. The price chart shows buyers gradually regaining control, with BTC climbing steadily throughout the past 24 hours and holding above the $60,000 threshold.

While concerns over inflation and the Federal Reserve's interest rate outlook continue to weigh on risk assets, Bitcoin has shown signs of stabilization after the recent wave of liquidations across the crypto market.

What investors should watch

Although the latest rebound has improved short-term sentiment, Bitcoin remains below the highs seen earlier this week, suggesting volatility could persist. Investors will likely monitor macroeconomic developments, institutional fund flows, and whether BTC can establish support above $60,000 before attempting another move higher.

💬

The Investor 06-27-26

Bitcoin fell about 2.5% on Friday, extending its recent decline as investors reacted to persistent U.S. inflation and renewed uncertainty surrounding U.S. cryptocurrency regulation.

Sentiment weakened after the CLARITY Act, a landmark bill aimed at establishing a comprehensive regulatory framework for digital assets, faced another delay in the U.S. Senate. The setback disappointed investors who had expected the legislation to provide greater regulatory certainty and support broader institutional participation in the crypto market.

Pressure also came from the latest U.S. inflation data. The Core PCE Price Index, the Federal Reserve's preferred inflation gauge, remained at 3.4% year-over-year in May, well above the Fed's 2% target, while headline PCE accelerated to 4.1% from 3.8% in April. The figures reinforced expectations that the Federal Reserve will keep interest rates elevated for longer, reducing the appeal of risk-sensitive assets such as cryptocurrencies.

Despite the pullback investors will continue to monitor progress on U.S. crypto legislation alongside upcoming economic data and Federal Reserve commentary, which are expected to remain the key drivers of digital asset sentiment.

💬

WS Investor 06-26-26

Bitcoin Extends Rally Above $66,500 as Risk Appetite Returns to Crypto Markets

Bitcoin climbed above $66,500 on Tuesday, gaining roughly 1.4% over the past 24 hours and more than 4.5% over the last five days, as investors continued to add exposure to digital assets amid improving market sentiment.

The world's largest cryptocurrency has recovered steadily from last week's weakness, benefiting from a broader rebound in risk assets and growing confidence that institutional demand remains strong. Bitcoin briefly pushed above $67,000 during the recent rally before consolidating near current levels.

The cryptocurrency's resilience comes despite ongoing geopolitical uncertainty and volatility across commodity markets. While oil prices have retreated as concerns about a broader Middle East conflict eased, Bitcoin has continued to attract buyers, suggesting investors are increasingly viewing the asset as a long-term growth opportunity rather than solely a speculative trade.

Institutional adoption remains a key pillar supporting the market. Spot Bitcoin ETFs continue to provide traditional investors with easier access to the cryptocurrency, while corporate and institutional interest in digital assets has remained elevated. Expectations that monetary policy could become more accommodative over the coming quarters have also supported demand for higher-risk assets, including cryptocurrencies.

Technical momentum has improved as Bitcoin reclaimed the $66,000 level and approached recent highs near $67,000. Market participants are now watching whether the cryptocurrency can establish a sustained move above that resistance zone, which could open the door for a retest of higher levels reached earlier this year.

Despite the recent gains, traders remain attentive to macroeconomic developments, central bank decisions, and geopolitical headlines that could influence risk appetite. For now, however, Bitcoin's steady advance suggests investor sentiment toward the cryptocurrency market remains constructive as the second half of 2026 begins.

💬

WS Investor 06-16-26

Bitcoin Holds Steady Near $62,500 as Investors Await Fresh Catalysts

Bitcoin traded near $62,600 (Thursday, 06.11.2026) showing little movement as investors weighed the latest U.S. economic data and broader market conditions. The world's largest cryptocurrency was down just 0.01%, reflecting a period of consolidation after recent volatility across financial markets.

The muted price action came as traders digested mixed signals from the U.S. economy. Initial jobless claims rose above expectations, pointing to some softening in the labor market, while producer prices increased more than forecast, highlighting persistent inflation pressures. The combination has created uncertainty about the timing and pace of future Federal Reserve interest-rate decisions.

Bitcoin has increasingly traded alongside risk assets in recent years, making macroeconomic developments a key driver of sentiment. Expectations for lower interest rates generally support cryptocurrencies by improving liquidity conditions and increasing investor appetite for higher-risk assets.

Despite the lack of a strong directional move, Bitcoin remains closely watched by investors as institutional adoption continues to grow and digital assets become more integrated into mainstream financial markets. Market participants are now looking for fresh economic data, central bank signals, and developments in the cryptocurrency sector to determine the next major move.

For now, Bitcoin appears to be holding its ground, with traders waiting for a clearer catalyst before committing to a stronger bullish or bearish view.

💬

European Investor 06-11-26

**Bitcoin Surges Nearly 3% as Investors Embrace Risk Following Softer Core Inflation Data**

Bitcoin climbed nearly 3% on Wednesday, rising to around $62,760 and reaching its highest level of the session as investors responded positively to the latest US inflation data and renewed appetite for risk assets.

The world's largest cryptocurrency gained momentum after the May Consumer Price Index report showed underlying inflation pressures easing more than expected. While headline inflation remained elevated at 4.2% year-over-year, Core CPI rose just 0.2% during the month, below economists' forecasts. The softer core reading strengthened hopes that the Federal Reserve may eventually gain room to ease monetary policy, a development that is generally supportive for cryptocurrencies and other risk-sensitive assets.

Bitcoin's rally also came despite weakness in US equity markets, where major indexes traded lower as investors weighed the broader inflation outlook and rising energy prices. The divergence suggests that cryptocurrency traders are focusing more on the prospect of future monetary easing than on short-term stock market volatility.

With inflation showing tentative signs of moderation and expectations for future interest-rate cuts remaining intact, the macroeconomic environment remains broadly supportive for digital assets. However, investors should also expect continued volatility as markets react to upcoming economic data and Federal Reserve commentary.

💬

European Investor 06-10-26

Bitcoin Slides 14% in Five Days as Capital Shifts Toward New Tech Opportunities and Higher Rates

Bitcoin has fallen roughly 14% over the past five days, extending a difficult period for the cryptocurrency market as investors navigate rising interest rates, shifting liquidity conditions and growing competition for capital from the technology sector.

The decline comes after stronger-than-expected U.S. economic data reinforced expectations that interest rates could remain elevated for longer. Higher Treasury yields and a stronger U.S. dollar have reduced the appeal of speculative assets, including cryptocurrencies, as investors seek safer alternatives with increasingly attractive yields.

At the same time, capital markets have been increasingly focused on a new wave of technology fundraising activity and anticipated initial public offerings. Investor attention has shifted toward artificial intelligence, space technology, robotics and advanced semiconductor companies, sectors that have attracted enormous amounts of capital over the past year. Market speculation surrounding potential blockbuster listings, including a possible future SpaceX IPO and other high-profile private technology companies, has contributed to a rotation of risk capital away from cryptocurrencies and toward equity opportunities that many investors view as offering more tangible growth prospects.

The technology sector has also become the primary destination for global investment flows as governments, corporations and institutional investors pour hundreds of billions of dollars into AI infrastructure, data centers and next-generation computing platforms. As a result, cryptocurrencies are increasingly competing with rapidly growing technology companies for the same pool of speculative and growth-oriented capital.

Another factor weighing on Bitcoin has been broader risk aversion across financial markets. Recent volatility in U.S. equities, uncertainty surrounding global growth, and concerns about inflation have encouraged investors to reduce exposure to higher-risk assets.

While the recent selloff has been severe, many analysts note that Bitcoin remains one of the most volatile major asset classes. In the near term, market direction will likely depend on Federal Reserve policy expectations, liquidity conditions and whether investors continue to favor technology and AI-related investments over digital assets. For now, the flow of capital appears to be moving toward traditional equity markets and emerging technology opportunities, creating additional pressure on cryptocurrency prices.

💬

The Investor 06-06-26

Bitcoin Slides as Risk Appetite Weakens Following Tech Selloff and Rising Market Uncertainty

Bitcoin fell nearly 4% today, dropping to around $64,300 and extending a volatile week for the cryptocurrency market. The decline comes as investors reduce exposure to risk assets amid a broad selloff in technology stocks, concerns about global growth, and ongoing geopolitical uncertainty.

One of the biggest catalysts behind today's weakness was the sharp post-earnings decline in Broadcom. Shares of the AI chip giant plunged more than 13% after investors reacted negatively to its outlook despite another strong quarter. The selloff spread across the semiconductor sector, dragging down Nvidia, AMD, Marvell and other technology names that have been at the center of the artificial intelligence investment boom. As enthusiasm surrounding AI stocks cools, speculative assets such as cryptocurrencies are also coming under pressure.

Bitcoin has increasingly traded like a high-beta technology asset during periods of market stress. When investors become more cautious and move away from growth stocks, cryptocurrencies often experience even larger swings. Today's decline reflects that dynamic as capital rotates toward safer assets such as gold, which gained more than 1% during the session.

The macroeconomic backdrop has also become more challenging. U.S. Initial Jobless Claims rose to 225,000, above expectations, adding to concerns that economic momentum may be slowing. Additional pressure has come from continued outflows from crypto investment products and concerns about large-holder selling activity.

Despite today's weakness, some analysts remain constructive on Bitcoin's longer-term outlook. Institutional adoption, expanding crypto infrastructure and a potentially more favorable regulatory environment could support prices over time. However, in the near term, Bitcoin appears highly sensitive to movements in technology stocks, interest-rate expectations and overall investor risk appetite. As long as uncertainty remains elevated, volatility is likely to remain a defining feature of the cryptocurrency market.

💬

European Investor 06-04-26

Bitcoin Falls as Stronger U.S. Economic Data Dampens Rate-Cut Hopes

Bitcoin traded about 1.5% lower on Wednesday, slipping to around $66,900 as investors reacted to stronger-than-expected U.S. economic data and a modest increase in risk aversion across financial markets.

The decline followed the release of the ADP employment report, which showed U.S. private employers added 122,000 jobs in May, slightly above expectations. The data reinforced the view that the U.S. economy remains resilient, reducing pressure on the Federal Reserve to cut interest rates aggressively in the near term. Higher-for-longer interest rates tend to be a headwind for cryptocurrencies because they increase the attractiveness of yield-bearing assets such as bonds and money market funds.

Broader market sentiment was also cautious. U.S. equity indexes moved lower during the session, while investors continued to monitor geopolitical tensions involving Iran, energy market volatility, and uncertainty surrounding global economic growth. These factors have encouraged some investors to reduce exposure to higher-risk assets.

Unlike previous periods when Bitcoin declines were driven by profit-taking after large rallies, today's weakness appears more closely tied to macroeconomic developments and shifting interest-rate expectations. Market participants are increasingly focused on upcoming economic releases, particularly Friday's U.S. nonfarm payrolls report, which could significantly influence expectations for Federal Reserve policy over the coming months.

Despite the pullback, Bitcoin continues to benefit from several longer-term structural drivers, including institutional adoption, spot Bitcoin ETF demand, and growing integration of digital assets into traditional financial markets. However, in the near term, crypto markets remain highly sensitive to interest-rate expectations and broader risk sentiment.

For now, traders appear to be taking a more cautious stance ahead of key economic data, with Bitcoin moving lower alongside other risk assets as markets reassess the timing and magnitude of potential Federal Reserve rate cuts later this year.

💬

Global Finance News 06-03-26

08-04-26WS News

08-03-26WS News

07-30-26European Investor

07-28-26WS News

NYSE:PLTRFollow

Palantir’s Stock Is Down 15% YTD: Should You Brace for More Volatility?

USFollow

S&P 500Follow

Earnings season is about to kick off — 2 charts reveal how it may go

Stock market today: Dow rises, S&P 500 and Nasdaq slip as US and Iran exchange fire, oil jumps

NYSE:CATFollow

NASDAQ Follow

Stock market today: Dow rises, S&P 500 and Nasdaq slip as US and Iran exchange fire, oil jumps

Dow Jones IndustrialFollow

NASDAQ:VRTXFollow

US FundsFollow

Sector Momentum Favors Defense; QQQ Yet To Break; Split NDX Breadth

VantagePoint A.I. Asset of the Week iShares Silver Trust ($SLV) - VantagePoint $SLV

NYSE:MRKFollow

Is Merck & Co., Inc. (MRK) the Most Reliable Dividend Stock to Buy According to Hedge Funds?

COINBASE:BTCUSDFollow

Live updates: Bitcoin holds $62,600 as the Iran conflict reignites and CPI looms

NYSE:PLTR

US

S&P 500

NYSE:CAT

NASDAQ

Dow Jones Industrial

NASDAQ:VRTX

US Funds

NYSE:MRK

COINBASE:BTCUSD